We are live on ! Find out more
PCAP

Pratt Collard Advisory Partners Portfolio holdings

AUM $150M
1-Year Est. Return 51.02%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+51.02%
3 Year Est. Return
+91.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$10.2M
Cap. Flow
+$1.84M
Cap. Flow %
1.23%
Top 10 Hldgs %
39.78%
Holding
100
New
3
Increased
32
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
DMRC icon
Digimarc Corp
DMRC
+$344K
2
CSCO icon
Cisco
CSCO
+$263K
3
CVS icon
CVS Health
CVS
+$260K
4
APD icon
Air Products & Chemicals
APD
+$258K
5
WST icon
West Pharmaceutical
WST
+$226K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$344K
2
KSU
Kansas City Southern
KSU
+$302K
3
EMR icon
Emerson Electric
EMR
+$249K
4
STT icon
State Street
STT
+$202K
5
OVV icon
Ovintiv
OVV
+$121K

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Consumer Staples 18.73%
3 Healthcare 17%
4 Financials 13.77%
5 Communication Services 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
26
Cisco
CSCO
$448B
$1.85M 1.23%
34,900
+5,003
+17% +$263K
TRV icon
27
Travelers Companies
TRV
$78.4B
$1.73M 1.15%
11,565
-12
-0.1% -$1.86K
WFC icon
28
Wells Fargo
WFC
$258B
$1.7M 1.13%
37,435
+400
+1% +$17.9K
CVX icon
29
Chevron
CVX
$383B
$1.67M 1.11%
15,905
+750
+5% +$79.2K
COST icon
30
Costco
COST
$423B
$1.6M 1.07%
4,047
+7
+0.2% +$2.65K
CDXS icon
31
Codexis
CDXS
$159M
$1.54M 1.03%
68,047
+300
+0.4% +$6.5K
XOM icon
32
ExxonMobil
XOM
$651B
$1.51M 1.01%
23,956
– –
FNV icon
33
Franco-Nevada
FNV
$42.7B
$1.5M 1%
10,352
+920
+10% +$133K
MMM icon
34
3M
MMM
$90.8B
$1.45M 0.96%
8,715
+66
+0.8% +$11K
VZ icon
35
Verizon
VZ
$193B
$1.42M 0.94%
25,256
+160
+0.6% +$9.18K
FDX icon
36
FedEx
FDX
$73B
$1.4M 0.93%
4,693
-75
-2% -$22.3K
TAP icon
37
Molson Coors Class B
TAP
$7.79B
$1.34M 0.89%
24,880
+450
+2% +$25.1K
CL icon
38
Colgate-Palmolive
CL
$73.3B
$1.3M 0.87%
15,993
– –
TXN icon
39
Texas Instruments
TXN
$255B
$1.29M 0.86%
6,718
– –
APD icon
40
Air Products & Chemicals
APD
$66.8B
$1.26M 0.84%
4,390
+880
+25% +$258K
WWD icon
41
Woodward
WWD
$21.2B
$1.23M 0.82%
10,024
– –
PFE icon
42
Pfizer
PFE
$142B
$1.19M 0.79%
30,299
+192
+0.6% +$7.47K
NVDA icon
43
NVIDIA
NVDA
$4.72T
$1.16M 0.77%
57,760
-680
-1% -$10.9K
IBM icon
44
IBM
IBM
$209B
$1.07M 0.72%
7,661
+738
+11% +$101K
OVV icon
45
Ovintiv
OVV
$17B
$1.07M 0.72%
34,120
-4,490
-12% -$121K
JPM icon
46
JPMorgan Chase
JPM
$933B
$1.04M 0.69%
6,683
-17
-0.3% -$2.67K
UNP icon
47
Union Pacific
UNP
$172B
$1.02M 0.68%
4,631
– –
HON icon
48
Honeywell
HON
$76.7B
$1.01M 0.67%
4,870
-27
-0.6% -$5.71K
WAT icon
49
Waters Corp
WAT
$37.3B
$944K 0.63%
2,730
-50
-2% -$15.8K
MA icon
50
Mastercard
MA
$510B
$888K 0.59%
2,431
– –
1
2
3 4

Similar funds

GAM
Geier Asset Management Marriottsville, Maryland $143M AUM
WFWM
Wechter Feldman Wealth Management Parsippany, New Jersey $143M AUM 25.17% 1-Year Est. Return
TWP
Treybourne Wealth Planners Greenwood, Indiana $162M AUM
TCM
Taal Capital Management Boston, Massachusetts $122M AUM 50.45% 1-Year Est. Return
LWPC
Legacy Wealth Partners (California) Calabasas, California $180M AUM 48.85% 1-Year Est. Return
RGM
ROAM Global Management New York $117M AUM
SFSIG
San Francisco Sentry Investment Group San Francisco, California $192M AUM 276.26% 1-Year Est. Return
CCM
Coe Capital Management Highland Park, Illinois $106M AUM 53.24% 1-Year Est. Return

Pratt Collard Advisory Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Pratt Collard Advisory Partners held 100 positions worth $150M, up 7.3% from $140M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pratt Collard Advisory Partners's Q2 2021 filing shows 3 new, 32 increased, 35 reduced and 3 closed positions. Its largest new stake was West Pharmaceutical: 685 shares worth $246K. The largest sale was AbbVie, an estimated $344K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Pratt Collard Advisory Partners's largest Q2 2021 buy was West Pharmaceutical: 685 shares worth $246K.
  • Pratt Collard Advisory Partners added most to Digimarc Corp in Q2 2021, an estimated $344K increase.
  • Pratt Collard Advisory Partners's biggest Q2 2021 reduction was AbbVie, cutting an estimated $344K.
  • Pratt Collard Advisory Partners fully exited Kansas City Southern in Q2 2021, selling an estimated $302K.
  • Pratt Collard Advisory Partners's ten largest holdings make up 40% of its $150M portfolio in Q2 2021.
  • Pratt Collard Advisory Partners opened 3 new positions and closed 3 in Q2 2021.
  • Pratt Collard Advisory Partners's portfolio value rose 7.3% quarter-over-quarter to $150M.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.